▽Clinical Infectious Diseases ●05/30 08:47 Risk of tuberculosis infection in young children exposed to multidrug-resistant tuberculosis in the TB-CHAMP multi-site randomised controlled trialSusan E Purchase and othersIn a randomized controlled trial, prevalence of tuberculosis infection in child MDR-TB contacts was 20.4% - lower than expected. Tuberculosis infection was strongly associated with cough duration in adult index patients and
▽The BMJ - Home ●05/30 08:44 Patients with severe ME/CFS need hope and expert multidisciplinary careLong term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort studyRFK Jr threatens to stop US scientists from publishing in major medical journalsThe Ethical Risk of Mismeasured Governance and Meaningless MetricThe fast evolving trajectories of HPAI A(H5N1) virus: Lots
▽AACE - Journal Issue ●05/30 07:53 NewsIs DIY Blown-In Insulation Really Worth the Savings? A Contractor’s Honest TakeBy Lakisha DavisMay 29, 2025Overcoming Challenges in Remote Work for Successful Software IntegrationEntertainmentMaximizing ROI from Instagram Live: The Power of Automated DMsBy Lakisha DavisMay 29, 20250From Billboards to Bots: The Evolution of Advertising in 100 YearsBy Lakisha DavisMay 29, 20250Business
▽Rheumatology Online first ●05/30 07:12 Accepted ManuscriptResearch Article 29 May 2025Ankylosed posterior spinal structures: the catalyst for syndesmophytes growth and impaired spinal mobility in axial spondyloarthritisSimin Liao and othersRheumatology, keaf199, https://doi.org/10.1093/rheumatology/keaf199Published: 29 May 2025 Section: Original ArticleAbstractView articleSupplementary dataAccepted ManuscriptBrief Report 29 M
▽Rheumatology -- Table of Contents ●05/30 06:55 Interferon-γ release assay as an emergent powerful biomarker in systemic lupus erythematosusYves Renaudineau and othersRheumatology, keaf186, https://doi.org/10.1093/rheumatology/keaf186Objectives To investigate the ex vivo IFN-γ release assay (IGRA) as a biomarker of SLE activity and disease outcome. Methods This retrospective study, conducted between 2008 and 2024 at a single tertiary care ce
